Search
Envista Holdings Corp
NVSTAdd to Watchlist
24.240USD
-0.060-0.25%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
3.94BMarket Cap
58.91P/E TTM
More Details of Envista Holdings Corp Company
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Envista Holdings Corp Info
Ticker SymbolNVST
Company nameEnvista Holdings Corp
IPO dateSep 18, 2019
CEOKeel (Paul A)
Number of employees12300
Security typeOrdinary Share
Fiscal year-endSep 18
Address200 S. Kraemer Blvd., Bldg. E
CityBREA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code92821
Phone17148175418
Websitehttps://envistaco.com/en
Ticker SymbolNVST
IPO dateSep 18, 2019
CEOKeel (Paul A)
Company Executives of Envista Holdings Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
167.63K
+58.15%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
40.16K
-26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
40.15K
-26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
34.23K
-30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
33.16K
-31.51%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
11.75K
-381.11%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
167.63K
+58.15%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
40.16K
-26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
40.15K
-26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
34.23K
-30.53%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
1.28B
47.12%
All Other
1.24B
45.74%
China
194.40M
7.15%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 5 hours ago
Updated: 5 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
8.63%
Ariel Investments, LLC
7.36%
Dimensional Fund Advisors, L.P.
6.01%
Franklin Mutual Advisers, LLC
4.91%
Vanguard Portfolio Management, LLC
4.65%
Other
68.45%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
8.63%
Ariel Investments, LLC
7.36%
Dimensional Fund Advisors, L.P.
6.01%
Franklin Mutual Advisers, LLC
4.91%
Vanguard Portfolio Management, LLC
4.65%
Other
68.45%
Shareholder Types
Shareholders
Proportion
Investment Advisor
63.03%
Investment Advisor/Hedge Fund
45.04%
Hedge Fund
11.93%
Pension Fund
1.41%
Sovereign Wealth Fund
1.36%
Research Firm
1.31%
Bank and Trust
0.56%
Individual Investor
0.48%
Private Equity
0.36%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
711
203.45M
125.03%
-3.29M
2025Q4
698
191.18M
116.72%
-29.60M
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
14.04M
8.57%
-276.49K
-1.93%
Dec 31, 2025
Ariel Investments, LLC
11.97M
7.3%
-33.66K
-0.28%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
9.63M
5.88%
+90.59K
+0.95%
Dec 31, 2025
Franklin Mutual Advisers, LLC
7.99M
4.87%
-705.06K
-8.11%
Dec 31, 2025
Atlanta Capital Management Company, L.L.C.
7.38M
4.5%
-1.29M
-14.85%
Dec 31, 2025
Victory Capital Management Inc.
6.06M
3.7%
+146.75K
+2.48%
Dec 31, 2025
AllianceBernstein L.P.
6.04M
3.68%
-62.95K
-1.03%
Dec 31, 2025
Gates Capital Management, Inc.
5.81M
3.54%
-414.85K
-6.67%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.75%
Schwab Ariel Opportunities ETF
Proportion1.51%
Pacer US Export Leaders ETF
Proportion0.88%
Distillate Small/Mid Cash Flow ETF
Proportion0.58%
Royce Quant Small-Cap Quality Value ETF
Proportion0.5%
Harbor Long-Short Equity ETF
Proportion0.45%
First Trust Health Care Alphadex Fund
Proportion0.41%
iShares U.S. Medical Devices ETF
Proportion0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.3%
DFA Dimensional US Small Cap Value ETF
Proportion0.27%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
